New Delhi, February 20, 2016: National Research Development Corporation (NRDC), an Enterprise of the Department of Scientific & Industrial Research, Ministry of Science & Technology, Govt. of India, New Delhi and M/s Dabur India Ltd., New Delhi have entered into License Agreements for commercialization of Ayush-64, an ayurvedic formulation for treatment of Malaria and Ayush-82, an ayurvedic Formulation for management of Diabetes both developed by Central Council for Research in Ayurvedic Sciences (CCRAS), New Delhi, an Autonomous body of the Ministry of AYUSH (Ayurveda, Yoga and naturopathy, Unani, Siddha and Homeopathy). The Licence agreements were signed by Dr. H. Purushotham on behalf of National Research Development Corporation, New Delhi and Dr. J. L. N. Sastry, Head Healthcare Research, on behalf of Dabur India Ltd., New Delhi at NRDC Office in the presence of Sh. B.N. Sarkar, Scientist (F), Department of Scientific and Industrial Research, New Delhi and Director, NRDC Board and other Senior executives of NRDC and Dabur. The Agreements were exchanged in the presence of the Minister of State, Ministry of AYUSH, Shri Shripad Yesso Naik and Secretary AYUSH, Shri Ajit M. Sharan, NRDC a Government Technology Licensing Agency has so far licensed about 10 technologies developed by CCRAS to more than 30 companies in India.
The Ayurvedic Drug Ayush-64 is very effective for the treatment of Malaria which is one of the most prevalent; destructive widely spread disease, well known to Ayurvedic Physicians as Visama Jvara from ancient times. In view of its wide prevalence and drug resistant malarial parasite, a poly-herbal non-toxic drug has been developed by CCRAS after carrying out extensive pharmacological, toxicological and Clinical studies.
Ayush-82 ; an anti diabetic drug also developed by CCRAS is a combination of known and tested hypoglycemic drugs
The use of these two drugs would help millions of people suffering from Malaria and Diabetes.
Corporate Comm India (CCI Newswire)
